Stats & Data
New Cost Cap industry-driven committee gets going
Members of the Office of Health Strategy’s (OHS) latest committee to drive down the growth in Connecticut’s healthcare spending moved past their initial reluctance to engage in their November and December meetings. OHS expects the provider and insurer-dominated committee to agree on ways to reduce their own costs/profits. Hopefully, they do not also use the…
Read MoreFAQs on OHS’s Primary Care Roadmap
Download the FAQs here Connecticut’s Office of Health Strategy has developed a Primary Care Roadmap to support primary care in Connecticut. OHS is accepting public comment on the draft Roadmap until the close of business Friday, January 14th. To send comments, email Tina.Hyde@ct.gov and put “Primary Care Roadmap” in the subject line. You should get…
Read MoreSign up for daily tips on the Art and Craft of Advocacy
You want to make a difference, but advocacy can be confusing, frustrating, and time-consuming. We can help. Sign up for Today’s Advocacy Tool – a month of inspiration, tips, and practical tools. Every weekday for a month, we’ll send an email with insight, best practices, and lessons we’ve learned from the updated CT Health Advocacy…
Read MoreHealth equity state scorecard finds CT compares well, but needs improvement
Connecticut ranks fifth best among states on overall health equity according to the Commonwealth Fund’s latest state scorecard, but every state has a lot of room for improvement. While whites in Connecticut scored in the 97th percentile for health system performance nationally, Latinx/Hispanic state residents scored at the 68th percentile, and Blacks in Connecticut scored…
Read MoreICER report on fair access to drugs prompts six insurers to change coverage policies
A powerful new scorecard from the Institute for Clinical and Economic Review (ICER) assessing 15 of the largest US formularies for barriers to accessing 28 fairly-priced drugs found generally good policies for clinical standards (96% are fair), step therapy (99%), and prescriber restrictions (100%). However, the report found poor policies for cost sharing tiers (77%)…
Read MoreLast year unjustified price increases for nine drugs cost US healthcare $1.67 billion, Humira accounted for $1.4 billion
According to this year’s report, last year the US health system spent an extra $1.67 billion on price increases for nine drugs that were not supported by clinical evidence. Humira led this year’s list at $1.4 billion, accounting for 84% of US unjustified drug price increases in 2020. Humira aside, the more modest price increases…
Read MoreCT ranks 15th among states in healthcare affordability, but that’s not saying much
Connecticut has implemented many policies to make healthcare affordable; unfortunately, they aren’t working. According to Altarum’s new Healthcare Affordability State Policy Scorecard, Connecticut earned 43.1 out of 80 possible points. There is a lot of room for improvement. Altarum ranked states on adoption of policies that can impact affordability and on outcomes, whether care is…
Read MoreCT Healthcare employment is slowly rebounding, except for nursing homes
Download the report Like other Connecticut workers, healthcare employment was hit hard by the pandemic in March 2020, according to data from the CT Department of Labor. Since then, hospital employment has partially rebounded but not in nursing and residential facilities. At its start, the COVID pandemic sharply increased demand in a few healthcare sectors…
Read MoreSign on letter voices deep concerns with primary care capitation
Today twenty-five independent advocates and providers signed a letter to the Office of Health Strategy opposing capitation of primary care services across Connecticut. The letter shares serious concerns with the Office of Health Strategy’s (OHS) plan to shift all primary care in Connecticut to a capitated payment model. The current concerns echo advocates’ and legislators’…
Read MoreConnecticut hospital systems vary in reducing low-value care
A new report published in JAMA Internal Medicine on low-value care provided to Medicare beneficiaries at the health system level offers actionable tools to improve effective care on the ground. Healthcare services that provide little or no health benefit, may harm patients, increase costs, and waste resources are low-value. Examples include prostate specific antigen testing…
Read More